Severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) was identified as a new
coronavirus causing pneumonia and acute respiratory distress syndrome. It has become a …

SARS-Cov-2 induces in severe cases a cytokine storm that ultimately leads to the activation
of coagulation cascade, causing thrombotic phenomena. 5 There is a further strong link …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with
arterial and venous thrombotic complications. In a US registry of patients with coronavirus …

May 4, 2020, there are> 1.2 million confirmed cases in the United States and> 66 000
deaths. Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and …

Objective Little is known about coronavirus disease 2019 (COVID-19)-associated
hypercoagulability. We sought to characterize patients with deep venous thrombosis (DVT) …

Abstract Coronavirus disease 19 (COVID-19) is a worldwide infection which was recently
declared a global health emergency by the WHO Emergency Committee. The most common …

Deep vein thrombosis (DVT) is prevalent in patients with coronavirus disease 2019 (COVID-
19). However, the risk factors and incidence rate of DVT remains elusive. Here, we aimed to …

COVID-19 is associated with a variety of clinical complications including coagulopathy,
which frequently results in venous thromboembolism (VTE). Retrospective analyses …

While acute respiratory infections are known to increase thrombosis risk [1], the incidence of
venous thromboembolic events (VTE) in patients with coronavirus disease 2019 (COVID-19) …

Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
appear to be at increased risk for venous thromboembolism (VTE), especially if they become …